Efficacy of two one‐week rabeprazole/levofloxacin‐based triple therapies for <i>Helicobacter pylori</i> infection

Abstract

This study demonstrates the efficacy of two 1-week rabeprazole-based triple therapies including levofloxacin to eradicate H. pylori. These regimens prove to be safe, well-tolerated, and achieved good eradication rates. Levofloxacin may be an effective alternative to clarithromycin in triple therapy regimens.